Outset Medical Statistics
Total Valuation
Outset Medical has a market cap or net worth of $80.08 million. The enterprise value is $24.99 million.
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Outset Medical has 18.54 million shares outstanding. The number of shares has increased by 312.52% in one year.
| Current Share Class | 18.54M |
| Shares Outstanding | 18.54M |
| Shares Change (YoY) | +312.52% |
| Shares Change (QoQ) | +3.12% |
| Owned by Insiders (%) | 2.23% |
| Owned by Institutions (%) | 70.16% |
| Float | 15.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.68 |
| Forward PS | 0.60 |
| PB Ratio | 0.72 |
| P/TBV Ratio | 0.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.29, with a Debt / Equity ratio of 0.91.
| Current Ratio | 6.29 |
| Quick Ratio | 4.84 |
| Debt / Equity | 0.91 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.89 |
Financial Efficiency
Return on equity (ROE) is -53.17% and return on invested capital (ROIC) is -17.46%.
| Return on Equity (ROE) | -53.17% |
| Return on Assets (ROA) | -15.26% |
| Return on Invested Capital (ROIC) | -17.46% |
| Return on Capital Employed (ROCE) | -31.74% |
| Weighted Average Cost of Capital (WACC) | 12.49% |
| Revenue Per Employee | $379,313 |
| Profits Per Employee | -$241,445 |
| Employee Count | 310 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.32 |
Taxes
In the past 12 months, Outset Medical has paid $820,000 in taxes.
| Income Tax | 820,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.77% in the last 52 weeks. The beta is 1.91, so Outset Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.91 |
| 52-Week Price Change | -76.77% |
| 50-Day Moving Average | 4.04 |
| 200-Day Moving Average | 7.41 |
| Relative Strength Index (RSI) | 54.64 |
| Average Volume (20 Days) | 177,302 |
Short Selling Information
The latest short interest is 2.01 million, so 10.84% of the outstanding shares have been sold short.
| Short Interest | 2.01M |
| Short Previous Month | 2.09M |
| Short % of Shares Out | 10.84% |
| Short % of Float | 12.89% |
| Short Ratio (days to cover) | 16.73 |
Income Statement
In the last 12 months, Outset Medical had revenue of $117.59 million and -$74.85 million in losses. Loss per share was -$4.15.
| Revenue | 117.59M |
| Gross Profit | 47.78M |
| Operating Income | -67.23M |
| Pretax Income | -74.03M |
| Net Income | -74.85M |
| EBITDA | -63.39M |
| EBIT | -67.23M |
| Loss Per Share | -$4.15 |
Full Income StatementBalance Sheet
The company has $156.71 million in cash and $101.61 million in debt, with a net cash position of $55.09 million or $2.97 per share.
| Cash & Cash Equivalents | 156.71M |
| Total Debt | 101.61M |
| Net Cash | 55.09M |
| Net Cash Per Share | $2.97 |
| Equity (Book Value) | 111.69M |
| Book Value Per Share | 6.03 |
| Working Capital | 199.10M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$33.51 million and capital expenditures -$740,000, giving a free cash flow of -$34.25 million.
| Operating Cash Flow | -33.51M |
| Capital Expenditures | -740,000 |
| Depreciation & Amortization | 3.84M |
| Net Borrowing | -5,000 |
| Free Cash Flow | -34.25M |
| FCF Per Share | -$1.85 |
Full Cash Flow StatementMargins
Gross margin is 40.64%, with operating and profit margins of -57.18% and -63.65%.
| Gross Margin | 40.64% |
| Operating Margin | -57.18% |
| Pretax Margin | -62.96% |
| Profit Margin | -63.65% |
| EBITDA Margin | -53.91% |
| EBIT Margin | -57.18% |
| FCF Margin | n/a |
Dividends & Yields
Outset Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -312.52% |
| Shareholder Yield | -312.52% |
| Earnings Yield | -93.47% |
| FCF Yield | -42.77% |
Analyst Forecast
The average price target for Outset Medical is $8.33, which is 92.82% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.33 |
| Price Target Difference | 92.82% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 11.41% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 20, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Mar 20, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
Outset Medical has an Altman Z-Score of -5.29 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.29 |
| Piotroski F-Score | 3 |
